UBS reiterates a 'Buy' Allscripts-Misys Healthcare (NASDAQ: MDRX), raises PT from $23 to $25.

UBS analyst says, "We reiterate our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE